<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33294084</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1916-7245</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Canadian respiratory journal</Title><ISOAbbreviation>Can Respir J</ISOAbbreviation></Journal><ArticleTitle>Detection of Viruses by Multiplex Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Nonresponding Community-Acquired Pneumonia.</ArticleTitle><Pagination><StartPage>8715756</StartPage><MedlinePgn>8715756</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8715756</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/8715756</ELocationID><Abstract><AbstractText Label="BACKGROUND">Nonresponding pneumonia is responsible for the most mortality of community-acquired pneumonia (CAP). However, thus far, it is not clear whether viral infection plays an important role in the etiology of nonresponding CAP and whether there is a significant difference in the clinical characteristics between viral and nonviral nonresponding CAP.</AbstractText><AbstractText Label="METHODS">From 2016 to 2019, nonresponding CAP patients were retrospectively enrolled in our study. All patients received bronchoalveolar lavage (BAL) and virus detection in BAL fluid by multiplex real-time polymerase chain reaction (PCR), and clinical, laboratory, and radiographic data were collected.</AbstractText><AbstractText Label="RESULTS">A total of 43 patients were included. The median age was 62 years, and 65.1% of patients were male. Overall, 20 patients (46.5%) were identified with viral infection. Of these viruses, influenza virus (<i>n</i>&#x2009;=&#x2009;8) and adenovirus (<i>n</i>&#x2009;=&#x2009;7) were more frequently detected, and others included herpes simplex virus, human enterovirus, cytomegalovirus, human coronavirus 229E, rhinovirus, and parainfluenza virus. Compared with nonviral nonresponding CAP, only ground-glass opacity combined with consolidation was a more common imaging manifestation in viral nonresponding CAP. However, no obvious differences were found in clinical and laboratory findings between the presence and the absence of viral infections.</AbstractText><AbstractText Label="CONCLUSIONS">Viral infections were particularly frequent in adults with nonresponding CAP. The ground-glass opacity combined with consolidation was a specific imaging manifestation for viral nonresponding CAP, while the clinical and laboratory data showed no obvious differences between viral and nonviral nonresponding CAP.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Hao Zhang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yinling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Zhangchu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Yinghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Fen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Huaqiong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shaobin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Medicine, Second Affiliated Hospital of Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Medicine, Second Affiliated Hospital of Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Huahao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wen</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-8981-8380</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fugui</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3060-9805</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can Respir J</MedlineTA><NlmUniqueID>9433332</NlmUniqueID><ISSNLinking>1198-2241</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="Y">Multiplex Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="Y">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33294084</ArticleId><ArticleId IdType="pmc">PMC7714605</ArticleId><ArticleId IdType="doi">10.1155/2020/8715756</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Infectious Diseases. 2018;18(11):1191&#x2013;1210. doi: 10.1016/S1473-3099(18)30310-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30310-4</ArticleId><ArticleId IdType="pmc">PMC6202443</ArticleId><ArticleId IdType="pubmed">30243584</ArticleId></ArticleIdList></Reference><Reference><Citation>File T. M. Community-acquired pneumonia. The Lancet. 2003;362(9400):1991&#x2013;2001. doi: 10.1016/s0140-6736(03)15021-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(03)15021-0</ArticleId><ArticleId IdType="pmc">PMC7119317</ArticleId><ArticleId IdType="pubmed">14683661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz M., Ewig S., Marcos M. A., et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine. 1999;160(2):397&#x2013;405. doi: 10.1164/ajrccm.160.2.9808045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.2.9808045</ArticleId><ArticleId IdType="pubmed">10430704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell L. A., Bartlett J. G., Dowell S. F., File T. M., Musher D. M., Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases. 2003;37(11):1405&#x2013;1433. doi: 10.1086/380488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/380488</ArticleId><ArticleId IdType="pmc">PMC7199894</ArticleId><ArticleId IdType="pubmed">14614663</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez R., Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007;132(4):1348&#x2013;1355. doi: 10.1378/chest.06-1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-1995</ArticleId><ArticleId IdType="pubmed">17934120</ArticleId></ArticleIdList></Reference><Reference><Citation>Low D. E., Mazzulli T., Marrie T. Progressive and nonresolving pneumonia. Current Opinion in Pulmonary Medicine. 2005;11(3):247&#x2013;252. doi: 10.1097/01.mcp.0000158727.20783.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mcp.0000158727.20783.70</ArticleId><ArticleId IdType="pubmed">15818188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Self W. H., Wunderink R. G., et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. New England Journal of Medicine. 2015;373(5):415&#x2013;427. doi: 10.1056/nejmoa1500245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1500245</ArticleId><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone J., Majumdar S. R., Fox J. D., Marrie T. J. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest. 2008;134(6):1141&#x2013;1148. doi: 10.1378/chest.08-0888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-0888</ArticleId><ArticleId IdType="pmc">PMC7094572</ArticleId><ArticleId IdType="pubmed">18689592</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings L. C., Anderson T. P., Beynon K. A., et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42&#x2013;48. doi: 10.1136/thx.2006.075077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.075077</ArticleId><ArticleId IdType="pubmed">17573440</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson N., Kalin M., Tiveljung&#x2010;Lindell A., Giske C. G., Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clinical Infectious Diseases. 2010;50(2):202&#x2013;209. doi: 10.1086/648678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/648678</ArticleId><ArticleId IdType="pmc">PMC7107844</ArticleId><ArticleId IdType="pubmed">20014950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman D., Shimoni A., Shemer-Avni Y., Keren-Naos A., Shtainberg R., Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138(4):811&#x2013;816. doi: 10.1378/chest.09-2717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-2717</ArticleId><ArticleId IdType="pmc">PMC7094496</ArticleId><ArticleId IdType="pubmed">20363845</ArticleId></ArticleIdList></Reference><Reference><Citation>Templeton K. E., Scheltinga S. A., van den Eeden W. C. J. F. M., Graffelman W. A., van den Broek P. J., Claas E. C. J. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clinical Infectious Diseases. 2005;41(3):345&#x2013;351. doi: 10.1086/431588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/431588</ArticleId><ArticleId IdType="pmc">PMC7107904</ArticleId><ArticleId IdType="pubmed">16007532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Wang Y., Liu Y., et al. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. The European Respiratory Journal. 2019;54(2) doi: 10.1183/13993003.02406-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02406-2018</ArticleId><ArticleId IdType="pubmed">31164430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman D., Lieberman D., Shimoni A., Keren-Naus A., Steinberg R., Shemer-Avni Y. Identification of respiratory viruses in adults: nasopharyngeal versus oropharyngeal sampling. Journal of Clinical Microbiology. 2009;47(11):3439&#x2013;3443. doi: 10.1128/jcm.00886-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00886-09</ArticleId><ArticleId IdType="pmc">PMC2772616</ArticleId><ArticleId IdType="pubmed">19726607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan F., Xiao Y., Li M., et al. Metagenomic analysis identified human rhinovirus B91 infection in an adult suffering from severe pneumonia. American Journal of Respiratory and Critical Care Medicine. 2017;195(11):1535&#x2013;1536. doi: 10.1164/rccm.201609-1908le.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201609-1908le</ArticleId><ArticleId IdType="pubmed">28569582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Pereira J., Concei&#xe7;&#xe3;o C., P&#xf3;voa P. Community-acquired pneumonia: identification and evaluation of nonresponders. Therapeutic Advances in Infectious Disease. 2013;1(1):5&#x2013;17. doi: 10.1177/2049936112469017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2049936112469017</ArticleId><ArticleId IdType="pmc">PMC4040717</ArticleId><ArticleId IdType="pubmed">25165541</ArticleId></ArticleIdList></Reference><Reference><Citation>Arancibia F., Ewig S., Martinez J. A., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. American Journal of Respiratory and Critical Care Medicine. 2000;162(1):154&#x2013;160. doi: 10.1164/ajrccm.162.1.9907023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.162.1.9907023</ArticleId><ArticleId IdType="pubmed">10903235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sialer S., Liapikou A., Torres A. What is the best approach to the nonresponding patient with community-acquired pneumonia? Infectious Disease Clinics of North America. 2013;27(1):189&#x2013;203. doi: 10.1016/j.idc.2012.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2012.11.009</ArticleId><ArticleId IdType="pubmed">23398874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros&#xf3;n B., Carratal&#xe0; J., Fern&#xe1;ndez-Sab&#xe9; N., Tubau F., Manresa F., Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Archives of Internal Medicine. 2004;164(5):502&#x2013;508. doi: 10.1001/archinte.164.5.502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.164.5.502</ArticleId><ArticleId IdType="pubmed">15006826</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliberti S., Amir A., Peyrani P., et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest. 2008;134(5):955&#x2013;962. doi: 10.1378/chest.08-0334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-0334</ArticleId><ArticleId IdType="pubmed">18583514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cill&#xf3;niz C., Ewig S., Ferrer M., et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Critical Care (London, England) 2011;15(5):p. R209. doi: 10.1186/cc10444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10444</ArticleId><ArticleId IdType="pmc">PMC3334753</ArticleId><ArticleId IdType="pubmed">21914220</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson N., Kalin M., Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scandinavian Journal of Infectious Diseases. 2011;43(8):609&#x2013;615. doi: 10.3109/00365548.2011.570785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.570785</ArticleId><ArticleId IdType="pubmed">21466255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruuskanen O., Lahti E., Jennings L. C., Murdoch D. R. Viral pneumonia. The Lancet. 2011;377(9773):1264&#x2013;1275. doi: 10.1016/s0140-6736(10)61459-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(10)61459-6</ArticleId><ArticleId IdType="pmc">PMC7138033</ArticleId><ArticleId IdType="pubmed">21435708</ArticleId></ArticleIdList></Reference><Reference><Citation>Men&#xe9;ndez R., Torres A., Zalaca&#xed;n R., et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59(11):960&#x2013;965. doi: 10.1136/thx.2003.017756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2003.017756</ArticleId><ArticleId IdType="pmc">PMC1746855</ArticleId><ArticleId IdType="pubmed">15516472</ArticleId></ArticleIdList></Reference><Reference><Citation>Moret I., Lorenzo M. J., Sarria B., et al. Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. European Respiratory Journal. 2011;38(5):1158&#x2013;1164. doi: 10.1183/09031936.00190410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00190410</ArticleId><ArticleId IdType="pubmed">21436352</ArticleId></ArticleIdList></Reference><Reference><Citation>Men&#xe9;ndez R., Cavalcanti M., Reyes S., et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008;63(5):447&#x2013;452. doi: 10.1136/thx.2007.086785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2007.086785</ArticleId><ArticleId IdType="pubmed">18245147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J. D., Singanayagam A., Hill A. T. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. The American Journal of Medicine. 2008;121(3):219&#x2013;225. doi: 10.1016/j.amjmed.2007.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2007.10.033</ArticleId><ArticleId IdType="pubmed">18328306</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf3;voa P. Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Current Opinion in Infectious Diseases. 2008;21(2):157&#x2013;162. doi: 10.1097/qco.0b013e3282f47c32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qco.0b013e3282f47c32</ArticleId><ArticleId IdType="pubmed">18317039</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho L. M., Salluh J. I., Soares M., et al. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Critical Care. 2012;16(2):p. R53. doi: 10.1186/cc11291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11291</ArticleId><ArticleId IdType="pmc">PMC3681380</ArticleId><ArticleId IdType="pubmed">22449513</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Eerden M. M., Vlaspolder F., de Graaff C. S., Groot T., Jansen H. M., Boersma W. G. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. European Journal of Clinical Microbiology and Infectious Diseases. 2005;24(4):241&#x2013;249. doi: 10.1007/s10096-005-1316-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-005-1316-8</ArticleId><ArticleId IdType="pubmed">15902529</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schutter I., De Wachter E., Crokaert F., et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clinical Infectious Diseases. 2011;52(12):1437&#x2013;1444. doi: 10.1093/cid/cir235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir235</ArticleId><ArticleId IdType="pmc">PMC7107807</ArticleId><ArticleId IdType="pubmed">21628484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira Gomes J. C., Pedreira W. L., Arau&#xf3;jo E. M. P. A., et al. Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy. Chest. 2000;118(6):1739&#x2013;1746. doi: 10.1378/chest.118.6.1739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.118.6.1739</ArticleId><ArticleId IdType="pubmed">11115467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz M., Arosio C., Salman P., Bauer T. T., Torres A. Diagnosis of pneumonia and monitoring of infection eradication. Drugs. 2000;60(6):1289&#x2013;1302. doi: 10.2165/00003495-200060060-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-200060060-00004</ArticleId><ArticleId IdType="pubmed">11152012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell L. A., Wunderink R. G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases. 2007;44(Suppl 2):S27&#x2013;S72. doi: 10.1086/511159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/511159</ArticleId><ArticleId IdType="pmc">PMC7107997</ArticleId><ArticleId IdType="pubmed">17278083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>